Switch / Start Evorel® 50
* Postmenopausal Women: >12 months since last period
Evorel 50 – Summary of Product Characteristics (SmPC)
Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please consult your doctor or nurse for further information.
If you have a medical query about a Consilient Health medicine, please contact Consilient Health at drugsafety@consilienthealth.com or +353 (0)1 2057766.
For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or irishoffice@consilienthealth.com
Copyright ©2021 Consilient Health Ltd. All rights reserved.
The information on this website is intended for patients who have been prescribed Evorel or Evorel Conti that reside in the Republic of Ireland only.
IE-EVC-11f(1) | Date of preparation: October 2022
